Page:Rapid Increase in Ivermectin Prescriptions and Reports of Severe Illness Associated with Use of Products Containing Ivermectin to Prevent or Treat COVID-19.pdf/4

This page has been proofread, but needs to be validated.

FDA MedWatch Adverse Event Reporting program
CDC Coronavirus (COVID-19) website
U.S. Government Coronavirus (COVID-19) website
American Association of Poison Control Centers
Press Release: American College of Medical Toxicology Reports Data on Adverse Effects and Toxicity from Unapproved Use of Ivermectin for the Prevention or Treatment of COVID-19
Treatments Your Healthcare Provider Might Recommend if You Are Sick

References
1 Lind JN, Lovegrove MC, Geller AI, Uyeki TM, Datta SD, Budnitz DS. Increase in Outpatient Ivermectin Dispensing in the US During the COVID-19 Pandemic: A Cross-Sectional Analysis. J Gen Intern Med. 2021 Jun 18:1–3. doi: 10.1007/s11606-021-06948-6.

The Centers for Disease Control and Prevention (CDC) protects people's health and safety by preventing and controlling diseases and injuries; enhances health decisions by providing credible information on critical health issues; and promotes healthy living through strong partnerships with local, national, and international organizations.


Categories of Health Alert Network messages:
Health AlertRequires immediate action or attention, highest level of importance
Health AdvisoryMay not require immediate action; provides important information for a specific incident or situation
Health UpdateUnlikely to require immediate action; provides updated information regarding an incident or situation
HAN Info ServiceDoes not require immediate action; provides general public health information

##This message was distributed to state and local health officers, state and local epidemiologists, state and local laboratory directors, public information officers, HAN coordinators, and clinician organizations##